Skip to content

Studing the Effect of Vitamin D Deficiency Treatment on Insulin Resistance

Studing the Effect of Vitamin D Deficiency Treatment on Insulin Resistance (Leptin to Adiponectin ratio) in Patients with Diabetes Mellitus

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015070623083N1
Enrollment
50
Registered
2016-05-15
Start date
2016-03-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Type 2 diabetes mellitus

Interventions

Vitamin D Supplementation.
Treatment - Drugs
Vitamin D Supplementation

Sponsors

Vice chancellor of research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age more than 18; Vitamin D deficiency( lower than 30 ng/ml) Exclusion criteria: Age more than 70; Severe underlying disease such as Malignancy, End-Stage Renal Disease, Cirrhosis, Connective tissue disease, Congestive Heart Failure; Pregnancy; Autoimmune disease such as Lupus; Acute or Chronic Infection; Psychiatric diseases under treatment; Recieving Vitamin D supplement during 1 month before study begins.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Leptin level. Timepoint: Baseline and After intervension. Method of measurement: Laboratory methods with Kits.;Level of vitamin D. Timepoint: Baseline and After intervension. Method of measurement: Laboratory methods with Kits.;Relation between Leptin, Adiponectin and Leptin to Adiponectin ratio after treating 25Hydroxy Vitamin D levels. Timepoint: After intervention. Method of measurement: Laboratory kits and then divide Leptin level to Adiponectin level.;Adiponectin level. Timepoint: Baseline and after intervension. Method of measurement: Laboratory methods with Kits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Haleh Rezaee

Tabriz University of Medical Sciences

rezaeeha@tbzmed.ac.ir+98 41 3337 2250

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026